Company news
Achieve Life Sciences, Inc. news in 2026
Achieve Life Sciences, Inc.'s news releases, calls and decks from 2026, newest first.
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
November 2, 2026
Achieve Life Sciences Presents 52-Week Cytisinicline Results for Smoking and Vaping Cessation at CHEST 2026
October 21, 2026
Achieve Life Sciences Appoints Kaitlyn Tuson as Senior Vice President, Marketing and Communications
October 7, 2026
Achieve Life Sciences Announces Granting of New Hire Inducement Awards
October 6, 2026
Achieve Life Sciences Appoints Benjamin Halladay as Chief Financial Officer
October 1, 2026
Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
September 28, 2026
Achieve Life Sciences Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 11, 2026
Achieve Life Sciences Appoints Ronald Dadino and Gloria Cosgrove to Lead CMC, Supply Chain, and Quality
August 3, 2026
Achieve Life Sciences Joins Russell 2000® Index
June 29, 2026
Achieve Life Sciences Receives Complete Response Letter from FDA for Cytisinicline NDA
June 22, 2026
Achieve Life Sciences Appoints Jeffrey Farrow and Reid Waldman, MD to Board of Directors
June 2, 2026
Achieve Life Sciences Presents Safety Data from 52 Weeks of Continuous Cytisinicline Treatment
May 19, 2026
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
May 12, 2026
Achieve Life Sciences Reports First Quarter 2026 Financial Results and Provides Business Updates
May 12, 2026
Achieve Life Sciences to Announce First Quarter 2026 Financial Results and Host Conference Call and Webcast on May 12, 2026
May 5, 2026
Amendment to Annual Report (Form 10-K/A)
April 30, 2026
Achieve Life Sciences Announces Up to $354 Million Private Placement
April 15, 2026
Achieve Life Sciences Announces Appointment of Andrew D. Goldberg, MD, as Chief Executive Officer and to the Board of Directors
April 15, 2026
Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions
April 14, 2026
Achieve Life Sciences Announces Publication in Nicotine & Tobacco Research Linking Cytisinicline's Receptor Selectivity to Low Nausea Rates and Favorable Tolerability
March 25, 2026
Achieve Life Sciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Updates
March 23, 2026
Achieve Life Sciences to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call and Webcast on March 24, 2026
March 17, 2026
Achieve Life Sciences Presents Data at SRNT Demonstrating Successful Cessation in Smokers with Extensive Prior Treatment Exposure; and on Participant Experience in the ORCA-OL Study
March 4, 2026
Achieve Life Sciences Announced Granting of New Hire Inducement Awards
January 30, 2026
Achieve Life Sciences Confirms Promotion of Dr. Mark Rubinstein to Chief Medical Officer
January 12, 2026
Calls in 2026
Decks in 2026
- Investor Presentation (July 2026)
Investor deck · 25 slides · July 2026